Bill Amendment: FL S7018 | 2024 | Regular Session

NOTE: For additional amemendments please see the Bill Drafting List

---

Bill Title: Health Care Innovation

Status: 2024-03-22 - Chapter No. 2024-16 [S7018 Detail]

Download: Florida-2024-S7018-Senate_Committee_Amendment_807142.html

---

       Florida Senate - 2024                        COMMITTEE AMENDMENT
       Bill No. SPB 7018
       
       
       
       
       
       
                                Ì807142}Î807142                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                                       .                                
                                       .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Health Policy (Harrell) recommended the
       following:
       
    1         Senate Amendment
    2  
    3         Delete lines 559 - 569
    4  and insert:
    5  a comprehensive financial and economic evaluation of the
    6  innovative solutions undertaken by the revolving loan program
    7  administered under this section. The evaluation must include,
    8  but need not be limited to, separate calculations of the state’s
    9  return and the economic value to residents of this state, as
   10  well as the identification of any cost savings to patients or
   11  the state and the impact on the state’s health care workforce.
   12         (b) Beginning October 1, 2030, and every 5 years
   13  thereafter, the Office of Program Policy Analysis and Government
   14  Accountability (OPPAGA) shall develop and present to the
   15  Governor, the President of the Senate, and the Speaker of the
   16  House of Representatives an evaluation of the administration and
   17  efficiency of the revolving loan program administered under this
   18  section. The evaluation must include, but need not be limited
   19  to, the degree to which the collective proposals increased
   20  efficiency in the health care system in this state, improved
   21  patient outcomes, increased public access to health care, and
   22  achieved the cost savings identified in paragraph (a) without
   23  reducing the quality of patient care.
   24         (c) Both the EDR and OPPAGA shall